Circulating vaspin and its relationship with insulin sensitivity, adiponectin, and liver histology in subjects with non-alcoholic steatohepatitis

Scandinavian Journal of Gastroenterology

Volumn 46, Issue 11, 2011, Pages 1355-1361

  Genc, Halil ^a   Dogru, Teoman ^a   Tapan, Serkan ^a   Kara, Muammer ^a   Ercin, Cemal Nuri ^a   Aslan, Fatih ^a   Kantarcioglu, Murat ^a   Karslioglu, Yildirim ^a   Sertoglu, Erdim ^a   Erbil, Mehmet Kemal ^a   Bagci, Sait ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Adiponectin; non alcoholic steatohepatitis; vaspin

Indexed keywords

ADIPONECTIN; GLUCOSE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VASPIN;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER BIOPSY; MALE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; WAIST CIRCUMFERENCE;

ADIPONECTIN; ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CHOLESTEROL, LDL; FATTY LIVER; HUMANS; INSULIN RESISTANCE; MALE; MULTIVARIATE ANALYSIS; SERPINS; WAIST CIRCUMFERENCE;

EID: 80054088904     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2011.603163     Document Type: Article

References (27)

1. Kotronen A, Yki-Järvinen H. Fatty liver: A novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 2008;28:27-38.
2. Tsochatzis EA, Manolakopoulos S, Papatheodoridis GV, Archimandritis AJ. Insulin resistance and metabolic syndrome in chronic liver diseases: Old entities with new implications. Scand J Gastroenterol 2009;44:6-14.
3. Torer N, Ozenirler S, Yucel A, Bukan N, Erdem O. Importance of cytokines, oxidative stress and expression of BCL-2 in the pathogenesis of non-alcoholic steatohepatitis. Scand J Gastroenterol 2007;42:1095-101.
4. Tsochatzis EA, Papatheodoridis GV, Archimandritis AJ. Adipokines in nonalcoholic steatohepatitis: From pathogenesis to implications in diagnosis and therapy. Mediators Inflamm 2009;2009:831670.
5. Hida K, Wada J, Eguchi J, Zhang H, Baba M, Seida A, et al. Visceral adipose tissue-derived serine protease inhibitor: A unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci 2005;26:10610-15.
6. Klöting N, Berndt J, Kralisch S, Kovacs P, Fasshauer M, Schön MR, et al. Vaspin gene expression in human adipose tissue: Association with obesity and type 2 diabetes. Biochem Biophys Res Commun 2006;339:430-6.
7. Youn BS, Klöting N, Kratzsch J, Park JW, Lee N, Song ES, et al. Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes 2008;57:372-7.
8. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
9. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-19.
10. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: Studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000;23:57-63.
11. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313-21.
12. Kukla M, Zwirska-Korczala K, Hartleb M, Waluga M, Chwist A, Kajor M, et al. Serum chemerin and vaspin in non-alcoholic fatty liver disease. Scand J Gastroenterol 2010; 45:235-42.
13. Aktas B, Yilmaz Y, Eren F, Yonal O, Kurt R, Alahdab YO, et al. Serum levels of vaspin, obestatin, and apelin-36 in patients with nonalcoholic fatty liver disease. Metabolism 2011;60:544-9.
14. Seeger J, Ziegelmeier M, Bachmann A, Lössner U, Kratzsch J, Blüher M, et al. Serum levels of the adipokine vaspin in relation to metabolic and renal parameters. J Clin Endocrinol Metab 2008;93:247-51.
15. Giomisi A, Kourtis A, Toulis KA, Anastasilakis AD, Makedou KG, Mouzaki M, et al. Serum vaspin levels in normal pregnancy in comparison with non-pregnant women. Eur J Endocrinol 2011;164:579-83.
16. El-Mesallamy HO, Kassem DH, El-Demerdash E, Amin AI. Vaspin and visfatin/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus. Metabolism 2011;60:63-70.
17. Gulcelik NE, Karakaya J, Gedik A, Usman A, Gurlek A. Serum vaspin levels in type 2 diabetic women in relation to microvascular complications. Eur J Endocrinol 2009;160: 65-70.
18. Kadoglou NP, Kapelouzou A, Tsanikidis H, Vitta I, Liapis CD, Sailer N. Effects of rosiglitazone/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-naïve patients with type 2 diabetes. Exp Clin Endocrinol Diabetes 2011;119:63-8.
19. Derosa G, Maffioli P, Salvadeo SA, Ferrari I, Gravina A, Mereu R, et al. Differential effects of candesartan and olmesartan on adipose tissue activity biomarkers in type II diabetic hypertensive patients. Hypertens Res 2010;33: 790-5.
20. Derosa G, Maffioli P, Salvadeo SA, Ferrari I, Gravina A, Mereu R, et al. Effects of combination of sibutramine and l-carnitine compared with sibutramine monotherapy on inflammatory parameters in diabetic patients. Metabolism 2011;60:421-9.
21. Dogru T, Karadurmus N, Tapan S, Genc H. Comment and reply on: Chemerin and vaspin in non-alcoholic fatty liver disease. Scand J Gastroenterol 2010;45:1000-1.
22. Guerre-Millo M. Adiponectin: An update. Diabetes Metab 2008;34:12-18.
23. Tilg H, Hotamisligil GS. Nonalcoholic fatty liver disease: Cytokine-adipokine interplay and regulation of insulin resistance. Gastroenterology 2006;131:934-45.
24. Lanthier N, Leclercq IA. Adiponectin in non-alcoholic steatohepatitis: An ideal culprit, but what are the proofs of its guilt? J Gastroenterol Hepatol 2009;24: 1584-6.
25. Ma H, Gomez V, Lu L, Yang X, Wu X, Xiao SY. Expression of adiponectin and its receptors in livers of morbidly obese patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2009;24:233-7.
26. Suleymanoglu S, Tascilar E, Pirgon O, Tapan S, Meral C, Abaci A. Vaspin and its correlation with insulin sensitivity indices in obese children. Diabetes Res Clin Pract 2009;3: 325-8.
27. Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 2002;51:2734-41.